Cargando…

Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes

BACKGROUND: The utility of serum biomarkers related to inflammation and adiposity as predictors of metabolic disease prevalence and outcomes after bariatric surgery are not well-defined. METHODS: Associations between pre- and post-operative serum levels of four biomarkers (C-reactive protein (CRP),...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Rourke, Robert W., Johnson, Geoffrey S., Purnell, Jonathan Q., Courcoulas, Anita P., Dakin, Gregory F., Garcia, Luis, Hinojosa, Marcelo, Mitchell, James E., Pomp, Alfons, Pories, Walter J., Spaniolas, Konstantinos, Flum, David R., Wahed, Abdus S., Wolfe, Bruce M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240401/
https://www.ncbi.nlm.nih.gov/pubmed/29777230
http://dx.doi.org/10.1038/s41366-018-0088-z
_version_ 1783371626442653696
author O’Rourke, Robert W.
Johnson, Geoffrey S.
Purnell, Jonathan Q.
Courcoulas, Anita P.
Dakin, Gregory F.
Garcia, Luis
Hinojosa, Marcelo
Mitchell, James E.
Pomp, Alfons
Pories, Walter J.
Spaniolas, Konstantinos
Flum, David R.
Wahed, Abdus S.
Wolfe, Bruce M.
author_facet O’Rourke, Robert W.
Johnson, Geoffrey S.
Purnell, Jonathan Q.
Courcoulas, Anita P.
Dakin, Gregory F.
Garcia, Luis
Hinojosa, Marcelo
Mitchell, James E.
Pomp, Alfons
Pories, Walter J.
Spaniolas, Konstantinos
Flum, David R.
Wahed, Abdus S.
Wolfe, Bruce M.
author_sort O’Rourke, Robert W.
collection PubMed
description BACKGROUND: The utility of serum biomarkers related to inflammation and adiposity as predictors of metabolic disease prevalence and outcomes after bariatric surgery are not well-defined. METHODS: Associations between pre- and post-operative serum levels of four biomarkers (C-reactive protein (CRP), cystatin C (CC), leptin, ghrelin) with baseline measures of adiposity and metabolic disease prevalence (asthma, diabetes, sleep apnea), and weight loss and metabolic disease remission after bariatric surgery were studied in the Longitudinal Assessment of Bariatric Surgery (LABS) cohort. RESULTS: Baseline CRP levels were positively associated with the odds of asthma but not diabetes or sleep apnea; baseline CC levels were positively associated with asthma, diabetes, and sleep apnea; baseline leptin levels were positively associated with asthma and negatively associated with diabetes and sleep apnea; baseline ghrelin levels were negatively associated with diabetes and sleep apnea. Increased weight loss was associated with increased baseline levels of leptin and CRP and decreased baseline levels of CC. Remission of diabetes and asthma was not associated with baseline levels of any biomarker. A higher likelihood of asthma remission was associated with a greater decrease in leptin levels, and a higher likelihood of diabetes remission was predicted by a lesser decrease in CC. Bariatric surgery was associated with decreased post-operative CC, CRP, and leptin levels, and increased post-operative ghrelin levels. CONCLUSION: This is the largest study to date of serum biomarkers of inflammation and adiposity in a bariatric surgery cohort. Biomarker levels correlate with metabolic disease prevalence prior to bariatric surgery, and with weight loss but not metabolic disease remission after surgery. Bariatric surgery regulates serum biomarker levels in a manner consistent with anti-inflammatory and compensatory orexigenic effects. These data contribute to our understanding of the mechanisms underlying the biologic effects of bariatric surgery.
format Online
Article
Text
id pubmed-6240401
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-62404012018-11-18 Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes O’Rourke, Robert W. Johnson, Geoffrey S. Purnell, Jonathan Q. Courcoulas, Anita P. Dakin, Gregory F. Garcia, Luis Hinojosa, Marcelo Mitchell, James E. Pomp, Alfons Pories, Walter J. Spaniolas, Konstantinos Flum, David R. Wahed, Abdus S. Wolfe, Bruce M. Int J Obes (Lond) Article BACKGROUND: The utility of serum biomarkers related to inflammation and adiposity as predictors of metabolic disease prevalence and outcomes after bariatric surgery are not well-defined. METHODS: Associations between pre- and post-operative serum levels of four biomarkers (C-reactive protein (CRP), cystatin C (CC), leptin, ghrelin) with baseline measures of adiposity and metabolic disease prevalence (asthma, diabetes, sleep apnea), and weight loss and metabolic disease remission after bariatric surgery were studied in the Longitudinal Assessment of Bariatric Surgery (LABS) cohort. RESULTS: Baseline CRP levels were positively associated with the odds of asthma but not diabetes or sleep apnea; baseline CC levels were positively associated with asthma, diabetes, and sleep apnea; baseline leptin levels were positively associated with asthma and negatively associated with diabetes and sleep apnea; baseline ghrelin levels were negatively associated with diabetes and sleep apnea. Increased weight loss was associated with increased baseline levels of leptin and CRP and decreased baseline levels of CC. Remission of diabetes and asthma was not associated with baseline levels of any biomarker. A higher likelihood of asthma remission was associated with a greater decrease in leptin levels, and a higher likelihood of diabetes remission was predicted by a lesser decrease in CC. Bariatric surgery was associated with decreased post-operative CC, CRP, and leptin levels, and increased post-operative ghrelin levels. CONCLUSION: This is the largest study to date of serum biomarkers of inflammation and adiposity in a bariatric surgery cohort. Biomarker levels correlate with metabolic disease prevalence prior to bariatric surgery, and with weight loss but not metabolic disease remission after surgery. Bariatric surgery regulates serum biomarker levels in a manner consistent with anti-inflammatory and compensatory orexigenic effects. These data contribute to our understanding of the mechanisms underlying the biologic effects of bariatric surgery. 2018-05-17 2019-02 /pmc/articles/PMC6240401/ /pubmed/29777230 http://dx.doi.org/10.1038/s41366-018-0088-z Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
O’Rourke, Robert W.
Johnson, Geoffrey S.
Purnell, Jonathan Q.
Courcoulas, Anita P.
Dakin, Gregory F.
Garcia, Luis
Hinojosa, Marcelo
Mitchell, James E.
Pomp, Alfons
Pories, Walter J.
Spaniolas, Konstantinos
Flum, David R.
Wahed, Abdus S.
Wolfe, Bruce M.
Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes
title Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes
title_full Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes
title_fullStr Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes
title_full_unstemmed Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes
title_short Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes
title_sort serum biomarkers of inflammation and adiposity in the labs cohort: associations with metabolic disease and surgical outcomes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240401/
https://www.ncbi.nlm.nih.gov/pubmed/29777230
http://dx.doi.org/10.1038/s41366-018-0088-z
work_keys_str_mv AT orourkerobertw serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes
AT johnsongeoffreys serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes
AT purnelljonathanq serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes
AT courcoulasanitap serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes
AT dakingregoryf serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes
AT garcialuis serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes
AT hinojosamarcelo serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes
AT mitchelljamese serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes
AT pompalfons serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes
AT porieswalterj serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes
AT spaniolaskonstantinos serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes
AT flumdavidr serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes
AT wahedabduss serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes
AT wolfebrucem serumbiomarkersofinflammationandadiposityinthelabscohortassociationswithmetabolicdiseaseandsurgicaloutcomes